Why does the mortality rate for fungal pneumonia remained elevated?

Updated: Jun 21, 2019
  • Author: Romeo A Mandanas, MD, FACP; Chief Editor: Guy W Soo Hoo, MD, MPH  more...
  • Print
Answer

Answer

The mortality due to fungal respiratory infections among immunosuppressed populations has remained elevated despite the arrival of new antifungal medications. The paucity of specific signs of infections and the low sensitivity of conventional culture-based methods for its diagnosis results in delayed initiation of antifungal therapy. [1]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!